Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres-Reference-Cited by-同舟云学术

Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres

Published:1985-09 Issue:S1 Volume:28 Page:615-640
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00290267.pdf

Reference34 articles.

1. Jarrett RJ (1984) The epidemiology of coronary heart disease and related factors in the context of diabetes mellitus and impaired glucose tolerance. In: Jarrett RJ (ed) Diabetes and heart disease. Elsevier, Amsterdam, pp 1–23

2. Robertson WB, Strong JP (1968) Atherosclerosis in persons with hypertension and diabetes mellitus. Lab Invest 18: 538–551

3. Jarrett RJ, Keen H, Grabauskas V (1979) The WHO Multinational Study of Vascular Disease in Diabetes: 1. General description. Diabetes Care 2: 175–186

4. WHO International Document (1982) Vascular disease in diabetics. Report of WHO Multinational Study of Vascular Disease in Diabetics. NCD/OND/79.4

5. Manual of Laboratory Operation, Lipid Research Clinics Program (1974) Vol 1 (DHEW Publication) [No. (NIH) 75-628]

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel perspective on cardiovascular adverse event profiles due to treatment with sodium-glucose transport protein 2 (SGLT2) inhibitors in the Japanese Adverse Drug Event Report (JADER) database;Personalized Medicine Universe;2023-11-30

2. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy;Cochrane Database of Systematic Reviews;2023-02-22

3. The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms;Journal of Clinical Medicine;2023-02-08

4. Role of insulin action in the pathogenesis of diabetic complications;Diabetology International;2022-09-07

5. Development and External Validation of a Nomogram and a Risk Table for Prediction of Type 2 Diabetic Kidney Disease Progression Based on a Retrospective Cohort Study in China;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-03